Taipei, Taiwan, 15 May 2017 – ASLAN Pharmaceuticals (ASLAN, 6497.TT), a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumour types, today announced its move to a new office in Taiwan with immediate effect.
The new location will allow ASLAN to support its growing business in Taiwan and the Asia region, further strengthening the Company’s capabilities and local presence.
Dr Carl Firth, CEO of ASLAN Pharmaceuticals said: “ASLAN is strongly committed to its business in Taiwan. With a growing presence, we look forward to continue contributing to the local biotech industry as well as working with clinicians and patients in the country.”
The Taiwan office is one of three regional offices in Asia Pacific that drives ASLAN’s clinical development strategy in the region. ASLAN has operational presence in Singapore, China and Australia.
The address and contact details of the new office are as follows:
ASLAN Pharmaceuticals Taiwan
35F, 68 Zhongxiao east road sec 5
Xinyi District, Taipei 110
Taiwan
Phone: +886 2 2758 3333
Fax: +886 2 2758 3321
Chris Fangv ASLAN Pharmaceuticals
Tel: +886 2 2758 3333
E-mail: media@aslanpharma.com
Emma Thompson / Stephanie Tan
Spurwing Communications
Tel: +65 6340 7287
Email: ASLAN@spurwingcomms.com
